UnitedHealth Group Inc (NYSE:UNH) had its target price lifted by investment analysts at Credit Suisse Group AG from $185.00 to $188.00 in a research note issued to investors on Wednesday. The firm presently has an “outperform” rating on the healthcare conglomerate’s stock. Credit Suisse Group AG’s price objective would suggest a potential upside of 9.60% from the stock’s previous close.

UNH has been the subject of several other reports. Vetr upgraded UnitedHealth Group from a “buy” rating to a “strong-buy” rating and set a $189.00 target price for the company in a report on Wednesday, December 28th. Cantor Fitzgerald initiated coverage on UnitedHealth Group in a report on Monday, February 6th. They issued an “overweight” rating and a $200.00 target price for the company. Jefferies Group LLC restated a “buy” rating and issued a $186.00 target price on shares of UnitedHealth Group in a report on Tuesday, January 10th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $188.00 target price for the company in a report on Thursday, March 2nd. Finally, Wells Fargo & Co reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, February 21st. One analyst has rated the stock with a hold rating and twenty-three have issued a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $181.05.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group (NYSE:UNH) traded up 1.35% on Wednesday, hitting $171.54. 3,652,113 shares of the company were exchanged. UnitedHealth Group has a 52-week low of $128.53 and a 52-week high of $172.19. The stock’s 50-day moving average price is $167.08 and its 200-day moving average price is $157.36. The stock has a market capitalization of $163.16 billion, a P/E ratio of 23.66 and a beta of 0.68. UnitedHealth Group also saw some unusual options trading on Monday. Stock investors purchased 333 put options on the stock. This represents an increase of 200% compared to the typical volume of 111 put options.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.20. The company earned $48.72 billion during the quarter, compared to analysts’ expectations of $48.21 billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The firm’s quarterly revenue was up 9.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.81 EPS. On average, equities research analysts anticipate that UnitedHealth Group will post $9.51 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 21st. Shareholders of record on Friday, March 10th were given a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 1.46%. The ex-dividend date was Wednesday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 33.47%.

TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) PT Raised to $188.00 at Credit Suisse Group AG” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.watchlistnews.com/unitedhealth-groups-unh-outperform-rating-reaffirmed-at-credit-suisse-group-ag/1203453.html.

In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Tuesday, February 14th. The stock was sold at an average price of $162.68, for a total value of $813,400.00. Following the sale, the director now owns 75,391 shares of the company’s stock, valued at approximately $12,264,607.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Michele J. Hooper sold 15,000 shares of the stock in a transaction dated Thursday, March 16th. The shares were sold at an average price of $170.89, for a total value of $2,563,350.00. Following the completion of the sale, the director now directly owns 35,941 shares in the company, valued at approximately $6,141,957.49. The disclosure for this sale can be found here. Insiders sold a total of 35,310 shares of company stock worth $5,855,416 in the last ninety days. 1.65% of the stock is owned by corporate insiders.

A number of large investors have recently bought and sold shares of the stock. Acadian Asset Management LLC increased its position in UnitedHealth Group by 46.8% in the third quarter. Acadian Asset Management LLC now owns 14,833 shares of the healthcare conglomerate’s stock worth $2,076,000 after buying an additional 4,729 shares during the last quarter. Mizuho Securities USA Inc. increased its position in UnitedHealth Group by 414.9% in the third quarter. Mizuho Securities USA Inc. now owns 30,814 shares of the healthcare conglomerate’s stock worth $4,314,000 after buying an additional 24,829 shares during the last quarter. PGGM Investments increased its position in UnitedHealth Group by 2.8% in the third quarter. PGGM Investments now owns 1,221,479 shares of the healthcare conglomerate’s stock worth $171,007,000 after buying an additional 32,855 shares during the last quarter. Oakbrook Investments LLC increased its position in UnitedHealth Group by 154.5% in the third quarter. Oakbrook Investments LLC now owns 54,075 shares of the healthcare conglomerate’s stock worth $7,571,000 after buying an additional 32,825 shares during the last quarter. Finally, Private Capital Advisors Inc. increased its position in UnitedHealth Group by 0.9% in the third quarter. Private Capital Advisors Inc. now owns 43,083 shares of the healthcare conglomerate’s stock worth $6,032,000 after buying an additional 400 shares during the last quarter. 86.67% of the stock is currently owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.